Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Palisade Bio (PALI) over the last 13 years, with Q1 2025 value amounting to $108600.0.

  • Palisade Bio's Gains from Investment Securities changed N/A to $108600.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $108600.0, marking a year-over-year change of. This contributed to the annual value of $50674.0 for FY2024, which is 1445.03% up from last year.
  • Palisade Bio's Gains from Investment Securities amounted to $108600.0 in Q1 2025.
  • In the past 5 years, Palisade Bio's Gains from Investment Securities ranged from a high of $2.7 million in Q2 2022 and a low of $2967.0 during Q1 2023
  • In the last 4 years, Palisade Bio's Gains from Investment Securities had a median value of $799562.0 in 2021 and averaged $1.1 million.
  • Per our database at Business Quant, Palisade Bio's Gains from Investment Securities surged by 23104.1% in 2022 and then crashed by 9987.92% in 2023.
  • Palisade Bio's Gains from Investment Securities (Quarter) stood at $799562.0 in 2021, then soared by 223.55% to $2.6 million in 2022, then crashed by 79.0% to $543188.0 in 2023, then tumbled by 80.01% to $108600.0 in 2025.
  • Its last three reported values are $108600.0 in Q1 2025, $543188.0 for Q3 2023, and $28997.0 during Q2 2023.